Skip to content

Bictegravir

Bictegravir (Biktarvy) appears in one listed tablet, the named brand. This antiretroviral ingredient forms part of a three-ingredient combination used for HIV-1 management. The complete formulation, strength and product directions define its place within treatment. Listed products differ in ingredient profile, form, strength, and pack size.

Biktarvy

Human Immunodeficiency Virus 1 (hiv-1) Infection

50mg + 200mg + 25mg

Intended to relieve retroviral burden to support clinical immune preservation and target viral replicative enzymes.

From$64.00/ tabletView

How does bictegravir work?

Bictegravir blocks integrase, an enzyme HIV uses to insert viral genetic material into human cells. Biktarvy forms part of HIV Management and combines this action with two other ingredients from the broader Antivirals category.

Important safety information for Bictegravir

Information about Bictegravir on this page is an educational overview, not medical advice. Products can differ in formulation, strength, and directions, and this content does not authorise clinical application or unsupervised use. Review the labelling for each product and speak with a healthcare professional whenever clinical judgement is needed. Product-specific contraindications, interactions, and reactions should be checked in the product labelling and verified clinical sources.